Clinical Report: Exploring Disparities in Gastric Cancer Among Asian American Subgroups
Overview
This report analyzes gastric cancer disparities among Asian American subgroups using SEER database data from 2000-2021. Findings indicate significant heterogeneity in survival rates, with South Asians showing the most favorable outcomes.
Background
Gastric cancer is a major health concern, particularly among Asian Americans, who experience higher incidence and mortality rates compared to White individuals. The diverse nature of the Asian American population necessitates a closer examination of gastric cancer outcomes across different ethnic subgroups to address health disparities effectively.
Data Highlights
Subgroup
5-Year Survival Rate
Localized Stage Diagnosis (%)
South Asians
Highest
29
Japanese
Lowest
29
Key Findings
16,321 Asian American patients with gastric cancer were analyzed.
29% of patients were diagnosed at a localized stage.
South Asian patients had the most favorable 5-year cancer-specific and overall survival rates.
Survival rates did not significantly improve for Chinese and Japanese patients from 2000-2010 to 2011-2021.
Increased localized-stage diagnosis and chemotherapy use were observed across subgroups.
Japanese patients had the lowest survival rates compared to White and Black patients.
Clinical Implications
Understanding the disparities in gastric cancer outcomes among Asian American subgroups can inform targeted screening and treatment strategies. Increased awareness of these differences may lead to improved early detection and management of gastric cancer in high-risk populations.
Conclusion
The study highlights the significant heterogeneity in gastric cancer outcomes among Asian American subgroups, emphasizing the need for tailored approaches to address these disparities.
